Differential expression of activator protein-2 isoforms in renal cell carcinoma

Mototsugu Oya1, Shuji Mikami, Ryuichi Mizuno

  • 1Department of Urology, Keio University School of Medicine, Tokyo, Japan.

Urology
|July 13, 2004
PubMed
Abstract

Insights

Activator protein-2 (AP-2) isoforms show varied expression in renal cell carcinoma (RCC). AP-2alpha is dominant in clear cell RCC, while AP-2beta is linked to early-stage carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Urology

Background:

  • Activator protein-2 (AP-2) is a transcription factor implicated in carcinogenesis and kidney development.
  • Three AP-2 isoforms (alpha, beta, gamma) share structural homology but have distinct functions.
  • Understanding AP-2 expression in renal cell carcinoma (RCC) is crucial for insights into tumorigenesis.

Purpose of the Study:

  • To investigate the differential expression of AP-2 isoforms (alpha, beta, gamma) in renal cell carcinoma (RCC) using immunohistochemistry.
  • To explore the correlation between AP-2 isoform expression and clinicopathological features of RCC.
  • To assess the potential role of AP-2 in the early stages of kidney cancer development.

Main Methods:

  • Immunohistochemistry was employed to evaluate the expression of AP-2alpha, AP-2beta, and AP-2gamma in 58 RCC tissue specimens.
  • Expression levels of epidermal growth factor receptor and erbB2 were also assessed in a subset of 42 RCC patients.
  • Statistical analysis was performed to determine correlations between AP-2 isoform expression and RCC subtypes and stages.

Main Results:

  • AP-2 isoforms exhibited differential expression patterns in normal renal tubules and RCC tissues.
  • AP-2alpha was significantly more expressed in clear cell RCC (25.9% overall, 14/41 clear cell) compared to non-clear cell subtypes (1/17).
  • AP-2beta was detected in 13.8% of cases, with higher expression in localized, low-stage tumors (pT1a), suggesting a role in early carcinogenesis. AP-2gamma expression was minimal (3.5%).

Conclusions:

  • AP-2 isoforms are differentially expressed in both normal adult kidneys and RCC.
  • AP-2alpha is a dominant isoform in clear cell renal cell carcinoma.
  • AP-2beta expression in early-stage RCC suggests its potential involvement in the initial phases of kidney cancer development.

Related Concept Videos

RNA Polymerase II Accessory Proteins02:36

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...